Skip to main content

Arcturus Therapeutics Holdings Inc.

ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001768224

No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.

Q3 2021 vs. Q2 2021

How the institutions holding Arcturus Therapeutics Holdings Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of ARCT: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders1391157+19
Shares20.5M60.9K19.1M−1.38M (−6.7%)
Value$694.0M$2.06M$909.0M+$217.1M (+31.4%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (35)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to ARCT in Q3 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC89,075$4.26M0.01%
Integral Health Asset Management, LLC85,000$4.06M1.17%
Altium Capital Management LP80,000$3.82M1.02%
Connor, Clark & Lunn Investment Management Ltd.78,082$3.73M0.02%
Granahan Investment Management Inc73,177$3.50M0.07%
Citadel Advisors LLC71,737$3.43M0.00%
Pictet Asset Management SA60,930$2.91M0.00%
PDT Partners, LLC49,500$2.37M0.17%
Marshall Wace North America L.P.39,972$1.91M0.01%
Bellevue Group AG34,500$1.65M0.02%
ExodusPoint Capital Management, LP21,937$1.05M0.02%
SG Americas Securities, LLC14,767$706.0K0.00%
Seven Eight Capital, LP14,100$674.0K0.06%
HRT Financial LP12,708$607.0K0.00%
Marshall Wace, LLP11,062$528.0K0.00%
Prudential Financial Inc8,510$407.0K0.00%
M&G Investment Management Ltd8,209$394.0K0.00%
Silverarc Capital Management, LLC6,208$297.0K0.17%
Schroder Investment Management Group6,150$294.0K0.00%
Ameriprise Financial Inc5,830$279.0K0.00%
Arizona State Retirement System5,736$274.0K0.00%
Tudor Investment Corp Et Al5,711$273.0K0.01%
Two Sigma Securities, LLC5,232$250.0K0.05%
Cresset Asset Management, LLC4,412$210.0K0.00%
STRS Ohio4,300$205.0K0.00%
Point72 Hong Kong Ltd2,422$116.0K0.01%
Amundi648$31.0K0.00%
Quantbot Technologies LP400$19.0K0.00%
Dark Forest Capital Management LP299$14.0K0.00%
AdvisorNet Financial, Inc200$10.0K0.00%
Koshinski Asset Management, Inc.200$9.56K0.00%
Sargent Bickham Lagudis LLC100$5.00K0.00%
Quadrant Capital Group LLC79$4.00K0.00%
Berman Capital Advisors, LLC13$00.00%
Meridian Wealth Partners, LLC8$00.00%

Sold out (16)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Not filed for Q3 2021 yet (1)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ARCT in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Pictet Asset Management Ltd60,930$2.06M